International Clinical Trial: Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117682) titled 'Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Cytori Therapeutics

Condition: Diminished Ovarian Reserve (DOR) Primary Ovarian Insufficiency (Poi) Ovarian Failure, Premature

Intervention: Device: Autologous Adipose-Derived Regenerative Cells (ADRCs) Intraovarian Injection

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment:...